Norcros plc announced an Investor Presentation Webinar to discuss its Interim Results for the 27 weeks ending 5th October 2025. The event, led by CEO Thomas Willcocks and CFO James Eyre, is open to ...
Artiva Biotherapeutics, Inc. (Nasdaq: ARTV) (Artiva), a clinical-stage biotechnology company whose mission is to develop ...
Q3 2025 Earnings Call Transcript November 11, 2025 Operator: Ladies and gentlemen, good afternoon. At this time, I would like ...
TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients ...
Q3 2025 Earnings Call November 12, 2025 7:30 AM ESTCompany ParticipantsSean Washchuk - Senior VP & CFOGeoffrey Martin ...
Over 100 patients treated with AlloNK across autoimmune and oncology indications Refractory rheumatoid arthritis (RA) prioritized as lead indication following FDA Fast Track Designation for AlloNK®, ...
Good morning, everyone, and welcome, everyone, to the Prelude Therapeutics Investor Conference Call. Today's call is being recorded and is expected to last up to 45 minutes. At this time, I will now ...
Case study with first patient images of half-life engineered MP0712 from compassionate care use show specific uptake in primary tumors and metastatic lesions MP0712 Radio-DARPin leverages rapid intern ...
Northern Nevada retail just received a spectacular upgrade. The Outlets at Legends in Sparks delivers metropolitan outlet excitement to the greater Reno region. This contemporary shopping destination ...
As financial institutions invest in their technology platforms, here are six key principles for modernizing systems without ...
It's time to stop chasing net worth and start chasing real worth. The question to ask yourself is: Does my financial plan support the life I want to live? Here's how to craft a plan that supports your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback